Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ADAP

Adaptimmune

$5.32

-0.02 (-0.37%)

, MRK

Merck

$64.93

0.38 (0.59%)

08:09
05/25/17
05/25
08:09
05/25/17
08:09
Hot Stocks
Adaptimmune initiates NY-ESO SPEAR T-cells study with Keytruda »

Adaptimmune Therapeutics…

ADAP

Adaptimmune

$5.32

-0.02 (-0.37%)

MRK

Merck

$64.93

0.38 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

MRK

Merck

$64.93

0.38 (0.59%)

08:02
05/25/17
05/25
08:02
05/25/17
08:02
Hot Stocks
Merck enters worldwide license agreement with Teijin for antibody candidate »

Merck announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

Tuesday
MRK

Merck

$64.55

0.51 (0.80%)

16:38
05/23/17
05/23
16:38
05/23/17
16:38
Hot Stocks
Merck says FDA approves new indication for KEYTRUDA »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

MRK

Merck

$64.55

0.505 (0.79%)

15:08
05/23/17
05/23
15:08
05/23/17
15:08
Hot Stocks
FDA grants accelerated approval to Merck cancer treatment based on biomarker »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

  • 22

    Sep

LOXO

Loxo Oncology

$46.35

0.21 (0.46%)

, RXDX

Ignyta

$6.80

-0.1 (-1.45%)

15:04
05/23/17
05/23
15:04
05/23/17
15:04
Periodicals
Loxo Oncology, Ignyta 'following Merck regulatory path,' Feuerstein says »

Adam Feuerstein of…

LOXO

Loxo Oncology

$46.35

0.21 (0.46%)

RXDX

Ignyta

$6.80

-0.1 (-1.45%)

MRK

Merck

$64.48

0.44 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 09

    Jun

  • 13

    Jun

  • 14

    Jun

  • 22

    Sep

MRK

Merck

$64.04

0.26 (0.41%)

06:56
05/23/17
05/23
06:56
05/23/17
06:56
Hot Stocks
FDA grants priority review to Merck's sBLA for KEYTRUDA »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

Monday
MRK

Merck

$64.16

0.375 (0.59%)

11:25
05/22/17
05/22
11:25
05/22/17
11:25
Hot Stocks
Merck says Phase 2 study results warrant continued evaluation of MK-7264 »

Merck announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

RDUS

Radius Health

$34.93

-0.07 (-0.20%)

, AMGN

Amgen

$156.51

-1.45 (-0.92%)

09:00
05/22/17
05/22
09:00
05/22/17
09:00
Recommendations
Radius Health, Amgen, Merck analyst commentary at Canaccord »

CV events 'may…

RDUS

Radius Health

$34.93

-0.07 (-0.20%)

AMGN

Amgen

$156.51

-1.45 (-0.92%)

MRK

Merck

$63.78

-0.11 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 13

    Jun

  • 14

    Jun

  • 30

    Jun

  • 19

    Jul

  • 14

    Aug

ABBV

AbbVie

$65.58

-0.05 (-0.08%)

, XOMA

XOMA

$6.41

-0.11 (-1.69%)

07:55
05/22/17
05/22
07:55
05/22/17
07:55
Conference/Events
UBS to hold a conference »

Global Healthcare…

ABBV

AbbVie

$65.58

-0.05 (-0.08%)

XOMA

XOMA

$6.41

-0.11 (-1.69%)

NVO

Novo Nordisk

$40.85

0.41 (1.01%)

PRSC

Providence Service

$46.73

0.11 (0.24%)

INCY

Incyte

$131.43

2.63 (2.04%)

FOLD

Amicus

$7.77

0.03 (0.39%)

CNC

Centene

$75.07

-0.55 (-0.73%)

MYL

Mylan

$37.94

-0.21 (-0.55%)

GMED

Globus Medical

$30.47

0.14 (0.46%)

UHS

Universal Health

$118.68

0.26 (0.22%)

TFX

Teleflex

$196.59

3.09 (1.60%)

XLRN

Acceleron

$25.56

-1.54 (-5.68%)

BOLD

Audentes Therapeutics

$17.43

0.47 (2.77%)

NKTR

Nektar

$18.95

-0.59 (-3.02%)

MMSI

Merit Medical

$33.55

0.45 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 01

    Jun

  • 01

    Jun

  • 02

    Jun

  • 06

    Jun

  • 13

    Jun

  • 16

    Jun

  • 22

    Jun

  • 03

    Sep

  • 09

    Oct

ABBV

AbbVie

$65.58

-0.05 (-0.08%)

, XOMA

XOMA

$6.41

-0.11 (-1.69%)

04:55
05/22/17
05/22
04:55
05/22/17
04:55
Conference/Events
UBS to hold a conference »

Global Healthcare…

ABBV

AbbVie

$65.58

-0.05 (-0.08%)

XOMA

XOMA

$6.41

-0.11 (-1.69%)

NVO

Novo Nordisk

$40.85

0.41 (1.01%)

PRSC

Providence Service

$46.73

0.11 (0.24%)

INCY

Incyte

$131.43

2.63 (2.04%)

FOLD

Amicus

$7.77

0.03 (0.39%)

CNC

Centene

$75.07

-0.55 (-0.73%)

MYL

Mylan

$37.94

-0.21 (-0.55%)

GMED

Globus Medical

$30.47

0.14 (0.46%)

UHS

Universal Health

$118.68

0.26 (0.22%)

TFX

Teleflex

$196.59

3.09 (1.60%)

XLRN

Acceleron

$25.56

-1.54 (-5.68%)

BOLD

Audentes Therapeutics

$17.43

0.47 (2.77%)

NKTR

Nektar

$18.95

-0.59 (-3.02%)

MMSI

Merit Medical

$33.55

0.45 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 01

    Jun

  • 01

    Jun

  • 02

    Jun

  • 06

    Jun

  • 13

    Jun

  • 16

    Jun

  • 22

    Jun

  • 03

    Sep

  • 09

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.